Ottóffy, M.; Mátrai, P.; Farkas, N.; Hegyi, P.; Czopf, L.; Márta, K.; Garami, A.; Balaskó, M.; Pótóné-Oláh, E.; Mikó, A.;
et al. Uninterrupted or Minimally Interrupted Direct Oral Anticoagulant Therapy is a Safe Alternative to Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation: An Updated Meta-Analysis. J. Clin. Med. 2020, 9, 3073.
https://doi.org/10.3390/jcm9103073
AMA Style
Ottóffy M, Mátrai P, Farkas N, Hegyi P, Czopf L, Márta K, Garami A, Balaskó M, Pótóné-Oláh E, Mikó A,
et al. Uninterrupted or Minimally Interrupted Direct Oral Anticoagulant Therapy is a Safe Alternative to Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation: An Updated Meta-Analysis. Journal of Clinical Medicine. 2020; 9(10):3073.
https://doi.org/10.3390/jcm9103073
Chicago/Turabian Style
Ottóffy, Máté, Péter Mátrai, Nelli Farkas, Péter Hegyi, László Czopf, Katalin Márta, András Garami, Márta Balaskó, Emőke Pótóné-Oláh, Alexandra Mikó,
and et al. 2020. "Uninterrupted or Minimally Interrupted Direct Oral Anticoagulant Therapy is a Safe Alternative to Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation: An Updated Meta-Analysis" Journal of Clinical Medicine 9, no. 10: 3073.
https://doi.org/10.3390/jcm9103073
APA Style
Ottóffy, M., Mátrai, P., Farkas, N., Hegyi, P., Czopf, L., Márta, K., Garami, A., Balaskó, M., Pótóné-Oláh, E., Mikó, A., Rostás, I., Wobbe, B., & Habon, T.
(2020). Uninterrupted or Minimally Interrupted Direct Oral Anticoagulant Therapy is a Safe Alternative to Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation: An Updated Meta-Analysis. Journal of Clinical Medicine, 9(10), 3073.
https://doi.org/10.3390/jcm9103073
